Why the study?
Does the PUCA-II single-valved pulsatile catheter-pump demonstrate acceptable valve leakage, flow resistance, and safety from thrombus formation in vitro and in vivo?
Does the PUCA-II single-valved pulsatile catheter-pump demonstrate acceptable valve leakage, flow resistance, and safety from thrombus formation in vitro and in vivo?
Answers are grounded in this paper and cite their sources.
The PUCA-II single-valved pulsatile catheter-pump demonstrated acceptable hemodynamic performance in vitro and feasible, thrombus-free short-term operation in vivo.
The Pulsatile Catheter (PUCA) pump is a trans-arterial pulsatile ventricular assist device that can be used for short-term left ventricular support. The separate inflow and outflow valves in the first version of the device (PUCA-I) were replaced by a single inflow/outflow valve in the latest PUCA pump version (PUCA-II). The new combined valve was tested during in vitro (mock circulation) and in vivo experiments for valve leakage, flow resistance, and thrombus formation. During the in vitro experiments a maximum valve leakage of 6% during ejection and 21% during aspiration was found. The maximum flow resistance coefficient (K) was 4. The animal experiments demonstrated that the PUCA-II could be positioned within a few minutes into the left ventricle without X-ray guidance and without using a vascular graft. Thrombi were not found in the combined valve after total pump time of 3 hours, which proved the good washout of the valve. Initial experiments to position the pump in the right ventricle through the pulmonary artery were successful and contributed to the development of a new application for the device.
No takes yet. Share an insight, caveat, or question.
Mihaylov et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: